Anticoagulants in heart disease: current status and perspectives.

Anticoagulants in heart disease: current status and perspectives.

Bibliografische gegevens
Hoofdauteurs:	De Caterina, R, Husted, S, Wallentin, L, Agnelli, G, Bachmann, F, Baigent, C, Jespersen, J, Kristensen, S, Montalescot, G, Siegbahn, A, Verheugt, F, Weitz, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2007

Gelijkaardige items

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.
door: De Caterina, R, et al.
Gepubliceerd in: (2013)

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
door: De Caterina, R, et al.
Gepubliceerd in: (2013)

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
door: De Caterina, R, et al.
Gepubliceerd in: (2013)

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
door: De Caterina, R, et al.
Gepubliceerd in: (2012)

[Expert consensus document on the use of antiplatelet agents].
door: Patrono, C, et al.
Gepubliceerd in: (2004)

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.
door: Patrono, C, et al.
Gepubliceerd in: (2004)

Antiplatelet agents for the treatment and prevention of atherothrombosis.
door: Patrono, C, et al.
Gepubliceerd in: (2011)

[Expert consensus document on the use of antiplatelet agents].
door: Patrono, C, et al.
Gepubliceerd in: (2004)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
door: Roberto C. Montoya, et al.
Gepubliceerd in: (2012-01-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
door: Verheugt Freek WA, et al.
Gepubliceerd in: (2001-05-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
door: Mohammadali Boroumand, et al.
Gepubliceerd in: (2010-04-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
door: Hamidreza Goodarzynejad, et al.
Gepubliceerd in: (2010-05-01)

New anticoagulants for the prevention of venous thromboembolism
door: Cecilia Becattini, et al.
Gepubliceerd in: (2010-04-01)

Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
door: Antonio Greco, et al.
Gepubliceerd in: (2020-04-01)

Epidemiological data on the use of traditional anticoagulants in cardiovascular disease
door: Reith, C, et al.
Gepubliceerd in: (2018)

Investigation of the current status of anticoagulant resistance in UK Norway rats by VKORC1 genotyping
door: Clarke, D. J., et al.
Gepubliceerd in: (2011-10-01)

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
door: Rocca, B, et al.
Gepubliceerd in: (2018)

The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
door: К. V. Lobastov, et al.
Gepubliceerd in: (2020-05-01)

Current Anticoagulation Statuses among Older Chinese People with Nonvalvular Atrial Fibrillation
door: Junrong Jiang, et al.
Gepubliceerd in: (2024-02-01)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
door: Collins, R, et al.
Gepubliceerd in: (1997)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome.
door: Åsa Johansson, et al.
Gepubliceerd in: (2015-01-01)

Oral anticoagulation – current knowlegde
door: Anna Karaś, et al.
Gepubliceerd in: (2022-10-01)

Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
door: Konstantinos I. Gkarmiris, et al.
Gepubliceerd in: (2024-04-01)

Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
door: S van Vugt, et al.
Gepubliceerd in: (2020-05-01)

CURRENT VIEW ON ANTICOAGULANT AND THROMBOLYTIC TREATMENT OF ACUTE PULMONARY EMBOLISM
door: G. A. Ignatenko, et al.
Gepubliceerd in: (2019-10-01)

Current status of heart transplantation in Turkey
door: Tahir Yağdı, et al.
Gepubliceerd in: (2014-12-01)

Current status of heart failure in China
door: Xiaotong Cui, et al.
Gepubliceerd in: (2017-01-01)

Current Controversies in Lupus Anticoagulant Detection
door: Gary W. Moore
Gepubliceerd in: (2016-12-01)

Current practice and effects of intravenous anticoagulant therapy in hospitalized acute heart failure patients with sinus rhythm
door: Hiroki Nakano, et al.
Gepubliceerd in: (2021-01-01)

Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol
door: HU Bachmann
Gepubliceerd in: (2004-06-01)

Anticoagulation for Pregnant Patients with Mechanical Heart Valves
door: Srivastava AR, et al.
Gepubliceerd in: (2007-01-01)

Postpartum anticoagulation in women with mechanical heart valves
door: Irani RA, et al.
Gepubliceerd in: (2018-10-01)

Clinical and hemodynamic results of heart valve replacement; hemostasis correction with anticoagulants
door: G. V. Arkadieva, et al.
Gepubliceerd in: (2005-06-01)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
door: Sofia Attelind, et al.
Gepubliceerd in: (2022-09-01)

The Current Status of Neuroprotection in Congenital Heart Disease
door: Kei Kobayashi, et al.
Gepubliceerd in: (2021-12-01)

Current status of rheumatic heart disease in India
door: P.C. Negi, et al.
Gepubliceerd in: (2019-01-01)

Antidote for new oral anticoagulants - present status
door: Abhijit S Nair, et al.
Gepubliceerd in: (2017-01-01)

Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
door: A. D. Aga, et al.
Gepubliceerd in: (2023-01-01)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
door: Emmanuel J. Favaloro, et al.
Gepubliceerd in: (2022-02-01)

THE ROLE OF ANTICOAGULATION THERAPY IN PATIENTS WITH PROSTHETIC HEART VALVES
door: N. A. Shostak, et al.
Gepubliceerd in: (2016-09-01)